Nom du produit:(3S)-3-(5-amino-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)(3-²H)piperidine-2,6-dione

IUPAC Name:(3S)-3-(5-amino-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)(3-²H)piperidine-2,6-dione

CAS:1620055-10-8
Formule moléculaire:C14H14N4O3
Pureté:95%+
Numéro de catalogue:CM1045885
Poids moléculaire:287.3

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1620055-10-8
Formule moléculaire:C14H14N4O3
Point de fusion:-
Code SMILES:[2H][C@@]1(CCC(=O)NC1=O)N1C(C)=NC2=C(C(N)=CC=C2)C1=O
Densité:
Numéro de catalogue:CM1045885
Poids moléculaire:287.3
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Related Products